BioSpace News Archive

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that recent clinical trial and real-world evidence on the efficacy and safety of Translarna™ (ataluren) in patients with nonsense mutation Duchenne muscular dystrophy (nmDMD) will be presented at the 27th International Annual Congress of the World Muscle Society (WMS) in Halifax, Nova Scotia, Canada.

Incyte announced that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, November 1, 2022.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the advancement of its investigational program targeting alpha-1 antitrypsin deficiency (AATD), a rare, genetic disease characterized by a protein folding defect that can lead to liver and lung disease.

Nimbus Therapeutics today announced it has entered into a research collaboration and exclusive, worldwide license agreement with Eli Lilly and Company (Lilly) for the development and commercialization of novel targeted therapies that activate a specific isoform of AMPK for the treatment of metabolic diseases.

AtriCure, Inc. today announced that it will release its third quarter 2022 financial results on Tuesday, November 1, 2022.

Aulos Bioscience today announced that initial safety data from patients who received monotherapy treatment in the Phase 1/2 trial of AU-007 will be presented at the upcoming Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting.

Dr. Reddy’s largest manufacturing facility in Bachupally, Hyderabad, joins Global Lighthouse Network of the World Economic Forum Journey started four years ago with digitisation of infrastructure and processes.

Sonitor® Continues to Lead the Way in RTLS and IPS Demonstrating its flagship Sense ™ Ultrasound-based RTLS Technology at the Oracle Cerner Healthcare Conference in Booth #701.

Bend Bioscience and QHP Capital (“QHP”), the management company for NovaQuest Private Equity (“NQPE”), have announced plans to invest in a new operation in Bend, Oregon , an emerging hub of biotechnology R&D and manufacturing.

ICR, a leading strategic communications and advisory firm, today announced that it will host the virtual “ ICR Healthcare Symposium: Biotech Investment Landscape – Sell Side Perspective” on Thursday, October 13, 2022 at 12 p.m. ET.